https://imedicine.trinxy.dev/innovative-medicines-group-ghn/2024-12-03T12:29:33-03:00https://imedicine.trinxy.dev/measles-on-the-rise-in-2024/2024-12-03T12:26:03-03:00https://imedicine.trinxy.dev/progress-towards-universal-health-coverage/2024-12-03T12:40:16-03:00https://imedicine.trinxy.dev/pharma-mergers-and-acquisitions-on-the-rise/2024-12-03T12:42:46-03:00https://imedicine.trinxy.dev/sustainability-in-the-pharmaceutical-industry-a-global-effort/2024-12-03T12:52:46-03:00https://imedicine.trinxy.dev/ai-drug-discovery/2024-12-03T12:57:12-03:00https://imedicine.trinxy.dev/new-research-explores-potential-treatment-for-ataxia-telangiectasia/2025-01-13T17:53:48-03:00https://imedicine.trinxy.dev/enzyme-replacement-therapy-shows-long-term-promise-for-alpha-mannosidosis/2025-01-13T17:53:34-03:00https://imedicine.trinxy.dev/sleimpn-2024-un-encuentro-de-aprendizaje-e-impacto/2025-01-13T18:00:15-03:00https://imedicine.trinxy.dev/innovative-medicines-annual-meeting-imam-2024/2025-01-13T18:03:54-03:00https://imedicine.trinxy.dev/rare-disease-research-in-latin-america-a-landscape-of-promise-and-potential/2025-01-16T11:58:57-03:00https://imedicine.trinxy.dev/img-appointed-as-wodas-exclusive-representative-in-latin-america/2025-11-10T18:36:03-03:00https://imedicine.trinxy.dev/immedica-and-innovative-medicines-group-sign-agreement-on-loargys-pegzilarginase-in-latin-america/2025-11-17T09:49:48-03:00